| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.0086 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.0081 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |